Sunday October 24th 2021
That is where the cans went
Federal Astrazeneca warehouse empty
Germany donates almost 18 million vaccine doses from the manufacturer Astrazeneca to other countries to protect against Covid-19. Now, according to a report, the federal warehouses are empty. But the distribution continues. For one manufacturer’s cans, Germany is only a kind of logistical link.
Germany has so far made 7.6 million corona vaccination doses from the manufacturer Astrazeneca available to other countries bilaterally. In addition, there are another ten million doses that the federal government has given to the World Health Organization (WHO) as part of the “Covax” vaccine initiative. “This means that there are no longer any stocks of Astrazeneca in stock on the part of the federal government,” said a spokesman for the Federal Ministry of Health of the editorial network in Germany.
Vietnam received most of the doses directly (2.6 million), followed by Ukraine (1.5), Egypt, Ghana (both 1.5) and Namibia (0.2). Also included in the listing are 350,000 cans to be shipped to Thailand. These deliveries are still pending. “The federal government intends to donate all vaccination doses that are not required for national needs, are pharmaceutically flawless and can still be shipped to third countries,” the spokesman emphasized.
Overall, the federal government has promised to provide 100 million vaccine doses from various manufacturers free of charge. Most of these are to be distributed via “Covax”. In addition, the federal government is investing 2.2 billion euros in the global fight against corona, including around 1.6 billion euros directly in the WHO initiative “Covax”.
In addition, since October all cans from the manufacturer “Johnson & Johnson” that have been delivered to Germany have been sent directly to “Covax”. The initiative aims to provide vaccinations to people around the world who are excluded from public health care. According to official information, the vaccine doses donated so far include five million doses that the federal government had collected from pharmaceutical wholesalers and the federal states due to a lack of demand.